-
1
-
-
0033504530
-
Bacteremic pneumonia due to staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms
-
Gonzalez C, Rubio M, Romero-Vivas J, et al. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29: 1171-7
-
(1999)
Clin Infect Dis
, vol.29
, pp. 1171-1177
-
-
Gonzalez, C.1
Rubio, M.2
Romero-Vivas, J.3
-
2
-
-
0242552187
-
Linezolid vs vancomycin: Analysis of two double-blind studies of patients with methicillin-resistant staphylococcus aureus nosocomial pneumonia
-
Wunderink RG, Rello J, Cammarata SK, et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003; 124: 1789-97
-
(2003)
Chest
, vol.124
, pp. 1789-1797
-
-
Wunderink, R.G.1
Rello, J.2
Cammarata, S.K.3
-
3
-
-
0034021097
-
Treatment of gram-positive nosocomial pneumonia: Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin
-
Fagon J, Patrick H, Haas DW, et al. Treatment of gram-positive nosocomial pneumonia: prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group. Am J Respir Crit Care Med 2000; 161: 753-62
-
(2000)
Nosocomial Pneumonia Group. Am J Respir Crit Care Med
, vol.161
, pp. 753-762
-
-
Fagon, J.1
Patrick, H.2
Haas, D.W.3
-
4
-
-
0035112879
-
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study
-
Rubinstein E, Cammarata S, Oliphant T, et al. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 2001; 32: 402-12
-
(2001)
Clin Infect Dis
, vol.32
, pp. 402-412
-
-
Rubinstein, E.1
Cammarata, S.2
Oliphant, T.3
-
5
-
-
13644269309
-
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
-
American Thoracic Society, Infectious Diseases Society of America
-
American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 388-416
-
-
-
6
-
-
33645662696
-
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant staphylococcus aureus pneumonia
-
Scheetz MH, Wunderink RG, Postelnick MJ, et al. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia. Pharmacotherapy 2006; 26: 539-50
-
(2006)
Pharmacotherapy
, vol.26
, pp. 539-550
-
-
Scheetz, M.H.1
Wunderink, R.G.2
Postelnick, M.J.3
-
7
-
-
33947116497
-
What does it mean: Appropriate therapy for methicillin-resistant staphylococcus aureus? [letter]
-
Viale P, Pea F. What does it mean: appropriate therapy for methicillin-resistant Staphylococcus aureus? [letter]. Crit Care Med 2007; 35: 991
-
(2007)
Crit Care Med
, vol.35
, pp. 991
-
-
Viale, P.1
Pea, F.2
-
8
-
-
3242688631
-
Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: Influence of disease severity
-
Clec'h C, Timsit JF, De Lassence A, et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity. Intensive Care Med 2004; 30: 1327-33
-
(2004)
Intensive Care Med
, vol.30
, pp. 1327-1333
-
-
Clec'h, C.1
Timsit, J.F.2
De Lassence, A.3
-
9
-
-
30144434179
-
Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: Maximizing clinical outcomes and minimizing selection of resistant organisms
-
Niederman MS. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Clin Infect Dis 2006; 42 Suppl. 2: S72-81
-
(2006)
Clin Infect Dis
, vol.42
, Issue.SUPPL. 2
-
-
Niederman, M.S.1
-
10
-
-
24944459102
-
Pneumonia caused by oxacillin-resistant staphylococcus aureus treated with glycopeptides
-
Rello J, Sole-Violan J, Sa-Borges M, et al. Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit Care Med 2005; 33: 1983-7
-
(2005)
Crit Care Med
, vol.33
, pp. 1983-1987
-
-
Rello, J.1
Sole-Violan, J.2
Sa-Borges, M.3
-
11
-
-
33644598029
-
Methicillin-resistant staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy
-
Shorr AF, Combes A, Kollef MH, et al. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 2006; 34: 700-6
-
(2006)
Crit Care Med
, vol.34
, pp. 700-706
-
-
Shorr, A.F.1
Combes, A.2
Kollef, M.H.3
-
12
-
-
33744823760
-
The antimicrobial therapy puzzle: Could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?
-
Pea F, Viale P. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Clin Infect Dis 2006; 42: 1764-71
-
(2006)
Clin Infect Dis
, vol.42
, pp. 1764-1771
-
-
Pea, F.1
Viale, P.2
-
13
-
-
33645118294
-
Effects of prolonged vancomycin administration on methicillin-resistant staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia
-
Sakoulas G, Gold HS, Cohen RA, et al. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. J Antimicrob Chemother 2006; 57: 699-704
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 699-704
-
-
Sakoulas, G.1
Gold, H.S.2
Cohen, R.A.3
-
14
-
-
29244442296
-
The pharmacokinetic and pharmacodynamic properties of vancomycin
-
Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 2006; 42 Suppl. 1: S35-9
-
(2006)
Clin Infect Dis
, vol.42
, Issue.SUPPL. 1
-
-
Rybak, M.J.1
-
15
-
-
7444254040
-
Pharmacodynamics of vancomycin and other antimicrobials in patients with staphylococcus aureus lower respiratory tract infections
-
Moise-Broder PA, Forrest A, Birmingham MC, et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 2004; 43: 925-42
-
(2004)
Clin Pharmacokinet
, vol.43
, pp. 925-942
-
-
Moise-Broder, P.A.1
Forrest, A.2
Birmingham, M.C.3
-
16
-
-
0027499255
-
Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients
-
Lamer C, de Beco V, Soler P, et al. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother 1993; 37: 281-6
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 281-286
-
-
Lamer, C.1
De Beco, V.2
Soler, P.3
-
17
-
-
33644853958
-
Monitoring of vancomycin serum levels for the treatment of staphylococcal infections
-
Kitzis MD, Goldstein FW. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections. Clin Microbiol Infect 2006; 12: 92-5
-
(2006)
Clin Microbiol Infect
, vol.12
, pp. 92-95
-
-
Kitzis, M.D.1
Goldstein, F.W.2
-
18
-
-
25144470553
-
Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and phar-macokinetic variability
-
Pea F, Viale P, Furlanut M. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and phar-macokinetic variability. Clin Pharmacokinet 2005; 44: 1009-34
-
(2005)
Clin Pharmacokinet
, vol.44
, pp. 1009-1034
-
-
Pea, F.1
Viale, P.2
Furlanut, M.3
-
19
-
-
0034119630
-
Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function: Multiple daily doses may be preferable
-
Pea F, Poz D, Baraldo M, et al. Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function: multiple daily doses may be preferable. Clin Drug Invest 2000; 19: 213-8
-
(2000)
Clin Drug Invest
, vol.19
, pp. 213-218
-
-
Pea, F.1
Poz, D.2
Baraldo, M.3
-
20
-
-
34247611015
-
Pharmacodynamics of antibiotics to treat multidrug-resistant grampositive hospital infections
-
Pea F, Viale P. Pharmacodynamics of antibiotics to treat multidrug-resistant Grampositive hospital infections. Expert Rev Anti Infect Ther 2007; 5: 255-70
-
(2007)
Expert Rev Anti Infect Ther
, vol.5
, pp. 255-270
-
-
Pea, F.1
Viale, P.2
-
21
-
-
33750950323
-
Increased vancomycin MICs for staphylococcus aureus clinical isolates from a university hospital during a 5-year period
-
Wang G, Hindler JF, Ward KW, et al. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 2006; 44: 3883-6
-
(2006)
J Clin Microbiol
, vol.44
, pp. 3883-3886
-
-
Wang, G.1
Hindler, J.F.2
Ward, K.W.3
-
22
-
-
17944367778
-
Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study
-
Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 2001; 45: 2460-7
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 2460-2467
-
-
Wysocki, M.1
Delatour, F.2
Faurisson, F.3
-
23
-
-
24944499018
-
MRSA pneumonia: Better outcome through continuous infusion of vancomycin?
-
Blot S. MRSA pneumonia: better outcome through continuous infusion of vancomycin? Crit Care Med 2005; 33: 2127-8
-
(2005)
Crit Care Med
, vol.33
, pp. 2127-2128
-
-
Blot, S.1
-
24
-
-
0031702762
-
Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant staphylococcus aureus and enterococcus faecalis
-
Klepser ME, Patel KB, Nicolau DP, et al. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. Pharmacotherapy 1998; 18: 1069-74
-
(1998)
Pharmacotherapy
, vol.18
, pp. 1069-1074
-
-
Klepser, M.E.1
Patel, K.B.2
Nicolau, D.P.3
-
25
-
-
33750082642
-
Predictors of mortality for methicillinresistant staphylococcus aureus health-care-associated pneumonia: Specific evaluation of vancomycin pharmacokinetic indices
-
Jeffres MN, Isakow W, Doherty JA, et al. Predictors of mortality for methicillinresistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 2006; 130: 947-55
-
(2006)
Chest
, vol.130
, pp. 947-955
-
-
Jeffres, M.N.1
Isakow, W.2
Doherty, J.A.3
-
26
-
-
33750285524
-
High-dose vancomycin therapy for methicillinresistant staphylococcus aureus infections: Efficacy and toxicity
-
Hidayat LK, Hsu DI, Quist R, et al. High-dose vancomycin therapy for methicillinresistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006; 166: 2138-44
-
(2006)
Arch Intern Med
, vol.166
, pp. 2138-2144
-
-
Hidayat, L.K.1
Hsu, D.I.2
Quist, R.3
-
27
-
-
33750137089
-
Management of persistent bacteremia caused by methicillin-resistant staphylococcus aureus: A survey of infectious diseases consultants
-
Hageman JC, Liedtke LA, Sunenshine RH, et al. Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants. Clin Infect Dis 2006; 43: e42-5
-
(2006)
Clin Infect Dis
, vol.43
-
-
Hageman, J.C.1
Liedtke, L.A.2
Sunenshine, R.H.3
|